| IBS and IBD In The News | |
FDA Recommends Approval of Zelmac for IBS in Women
Novartis June 27, 2000| Other News | |
The US Food and Drug Administration recommended the approval of Zelmac to treat abdominal pain and constipation in women with Irritable Bowel Syndrome. IBS affects up to 20% of people in the Western population, and symptoms include diarrhea, constipation, and pain.
Zelmac was well tolerated in a clinical trial involving more than 2,000 patients. A common side effect was diarrhea, which was normally resolved without discontinuing treatment. Other side effects were comparable to the placebo.
| Featured Links | |
IBS 101
The basics about irritable bowel syndrome including symptoms and treatment.Frequently Asked Questions: IBS
Answers to the most frequently asked questions about IBS.IBS Drugs
Links to information about other drugs used to treat IBS.
